Trial Profile
A Randomized Trial of Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 15 Nov 2021
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary) ; Alprostadil/papaverine/phentolamine
- Indications Erectile dysfunction
- Focus Therapeutic Use
- 09 Nov 2021 Status changed from completed to discontinued.
- 10 Dec 2020 Status changed from active, no longer recruiting to completed.
- 08 Sep 2020 Planned End Date changed from 1 Aug 2020 to 1 Aug 2021.